Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines. They specialize in developing therapies for areas of high unmet medical need. Lisata Therapeutics offers a broad pipeline of potential treatments targeting cancer and other serious diseases.

Their pipeline includes therapies for pancreatic cancer, advanced solid tumors, coronary microvascular dysfunction, critical limb ischemia, diabetic kidney disease, and more. They utilize cutting-edge technologies such as the CendR Platform® and CD34+ Cell Therapy Platform to enhance drug delivery to solid tumors and promote the development of new microvasculature. Lisata Therapeutics is committed to transforming patient lives and offers rewarding career opportunities for individuals passionate about advancing scientific research.

Visit their website to learn more about their innovative therapies and join their mission to make a meaningful contribution to patients in need